ClinicalTrials.Veeva
Menu

Find clinical trials for Asthma in Chicago, IL

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Pulmonary Eosinophilia
Allergic Rhinitis
Disease
Lung Diseases
Rhinitis
Chronic Obstructive Pulmonary Disease
Respiratory Tract Diseases

Asthma trials near Chicago, IL, USA:

Prevention of Asthma Exacerbations Using Dupilumab in Urban Children and Adolescents (PANDA)

This is a multi-center, double-blind, placebo-controlled, randomized trial of dupilumab adjunctive therapy for prevention of asthma exacerba....

Active, not recruiting
Asthma
Drug: Placebo
Drug: Dupilumab

Phase 2

National Institute of Allergy and Infectious Diseases (NIAID)
National Institute of Allergy and Infectious Diseases (NIAID)

Chicago, Illinois, United States and 7 other locations

The objective of this study is to assess the potential for GB-0895 treatment to improve the health of adolescents and adults with severe asthma...

Enrolling
Severe Asthma
Drug: Placebo
Drug: GB-0895

Phase 3

Generate Biomedicines

Glenview, Illinois, United States and 95 other locations

The purpose of this study is to evaluate dexpramipexole as an add-on oral therapy in participants with inadequately controlled eosinophilic asthma...

Active, not recruiting
Asthma Attack
Asthma; Eosinophilic
Drug: Dexpramipexole Dihydrochloride
Drug: Placebo

Phase 3

Areteia Therapeutics

Chicago, Illinois, United States and 335 other locations

Phase 2 study to evaluate the safety, tolerability, PK, immunogenicity, and pharmacodynamics of solriktug with adult participants with asthma...

Active, not recruiting
Asthma
Biological: NSI-8226
Biological: Placebo

Phase 2

Uniquity One (UNI)

Winfield, Illinois, United States and 70 other locations

This study is trying to find the right dose of a long-lasting medicine called GSK5784283 for people with asthma that remains uncontrolled ev...

Active, not recruiting
Asthma
Drug: GSK5784283
Drug: Placebo

Phase 2

GlaxoSmithKline (GSK)
GlaxoSmithKline (GSK)

Skokie, Illinois, United States and 134 other locations

Phase 2 Dose Ranging Study to Evaluate the Efficacy and Safety of Frevecitinib (KN-002) Over a 12-Week Treatment Period in Patients With Severe Asthma...

Enrolling
Severe Asthma
Drug: Placebo
Drug: Frevecitinib

Phase 2

Kinaset Therapeutics

Chicago, Illinois, United States and 14 other locations

The study is being conducted to evaluate the effect of 3 dosing regimens of povorcitinib on pulmonary function

Active, not recruiting
Moderate to Severe Asthma
Drug: ICS-LABA
Other: placebo

Phase 2

Incyte
Incyte

Glenview, Illinois, United States and 83 other locations

treatment in children 2 to \<6 years of age with uncontrolled asthma and/or recurrent severe asthmatic wheeze. The study will be conducted i...

Invitation-only
Asthma
Wheezing
Drug: Placebo
Drug: Dupilumab

Phase 3

Sanofi
Sanofi

Chicago, Illinois, United States and 74 other locations

This study is researching a drug called dupilumab. The study is focused on patients who have uncontrolled asthma. Asthma is a condi...

Active, not recruiting
Asthma
Drug: dupilumab
Drug: Matching Placebo

Phase 4

Regeneron Pharmaceuticals
Regeneron Pharmaceuticals

River Forest, Illinois, United States and 77 other locations

levels compared with placebo in participants with moderate-to-severe asthma.Study participation will last approximately 65 weeks, including ...

Enrolling
Asthma
Drug: Brenipatide
Drug: Placebo

Phase 2

Lilly
Lilly

Westchester, Illinois, United States and 119 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems